- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03491982
Compliance Feasibility Study for Remote Phase 2 Cardiac Rehabilitation
Study Overview
Status
Intervention / Treatment
Detailed Description
In spite of the fact that cardiac rehabilitation has been shown to be beneficial to patients who have had a cardiac event, such as a heart attack, only 5% of eligible patients complete this program. Some of the reasons cited include limited facility access, travel time and cost.
We are testing the hypothesis that cardiac rehab compliance will be greater if patients are offered the opportunity, and associated technology, to perform cardiac rehab anywhere.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63117
- Saint Louis University - SLUCare
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- referred to SLU cardiac rehab facility
Exclusion Criteria:
- does not own app compatible smart phone
- dementia
- syncope
- valvular disease
- life expectancy < 1 year
- non-English speaking
- unstable angina
- decompensated congestive heart failure
- ventricular arrhythmia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percentage of patients completing remote rehab program compared to case controls
Time Frame: Immediately after cardiac rehab completion or stoppage
|
Immediately after cardiac rehab completion or stoppage
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Six minute walk test compared to case controls
Time Frame: Immediately after cardiac rehab completion or stoppage
|
Immediately after cardiac rehab completion or stoppage
|
|
depression score vs case controls
Time Frame: Immediately after cardiac rehab completion or stoppage
|
Immediately after cardiac rehab completion or stoppage
|
|
Average number of minutes in exercise rehab compared to case controls
Time Frame: Immediately after cardiac rehab completion or stoppage
|
Immediately after cardiac rehab completion or stoppage
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lisa Alderson, MD, St. Louis University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 28544
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.